Showing 181 - 200 results of 27,642 for search '(( 5 ht decrease ) OR ( 50 ((((mg decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 0.69s Refine Results
  1. 181
  2. 182

    Anti-transforming growth factor beta (TGFβ) Ab decreased aristolochic acid (AA)-induced reticulum endoplasmic (ER) and mitochondrial (MT) stress protein expression in kidney tissue... by Agnieszka A. Pozdzik (3159222)

    Published 2016
    “…<p>(<b>a</b>) Tissue lysates from kidney cortex, outer stripe of outer medulla (OSOM) and inner stripe of outer medulla (ISOM) were immunoblotted for p-IRE1α, GRP78, p-eIF2α, CHOP and glyceraldehyd 3-phosphate dehydrogenase (GAPDH) expression. …”
  3. 183
  4. 184

    Respiratory network responses to systemic 5-HT<sub>2A</sub>R and 5-HT<sub>2B</sub>R activation. by Marcus Niebert (183419)

    Published 2013
    “…PNA frequency decreased below control. (<b>B</b>) Application of the 5-HT<sub>2B</sub>R agonist BW 723C86 increased PNA frequency. …”
  5. 185

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
  6. 186

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
  7. 187
  8. 188
  9. 189
  10. 190
  11. 191
  12. 192

    Human 5-HT<sub>4</sub>-based RASSLs. by Wei Chun Chang (43479)

    Published 2007
    “…Rs1.2 is Rs1 with an extra D<sup>66</sup>A mutation that decreased constitutive G<sub>s</sub> signaling. Rs1.3 is the Rs1-i3-5-HT<sub>1A</sub> chimera with G<sub>i</sub> signaling. …”
  13. 193
  14. 194
  15. 195
  16. 196
  17. 197
  18. 198
  19. 199
  20. 200